HomeInsightsPE

Torrent Pharmaceuticals Ltd PE Ratio

Torrent Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 1.5 Cr

Volume Transacted

(Dec 6, 2024)

stocks purchased

4.6 K

Stocks Traded

(Dec 6, 2024)

Last Updated on: Dec 06, 2024

Image

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM

PE

65.4

Last updated on: Dec 06, 2024

Key Highlights

  • The P/E Ratio of Torrent Pharmaceuticals Ltd is 65.4 as of 06 Dec 15:30 PM .
  • The P/E Ratio of Torrent Pharmaceuticals Ltd changed from 75.7 on March 2019 to 53.2 on March 2024 . This represents a CAGR of -5.71% over 6 years.
  • The Latest Trading Price of Torrent Pharmaceuticals Ltd is ₹ 3332 as of 06 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Torrent Pharmaceuticals Ltd

No data available

Company Fundamentals for Torrent Pharmaceuticals Ltd

No data available

Image

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM

Share Price

₹ 3332.25

-30.70 (-0.91%)

stock direction

Last updated on: Dec 06, 2024

Market Price of Torrent Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Torrent Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Dec 20243332.25
05 Dec 20243362.95
04 Dec 20243349.6
03 Dec 20243361.6
02 Dec 20243338.4
29 Nov 20243326.9
28 Nov 20243203.85
27 Nov 20243223.15
26 Nov 20243226.75
25 Nov 20243268

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Torrent Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Torrent Pharmaceuticals Ltd651,13,812
Sun Pharmaceuticals Industries Ltd384,33,032
Divis Laboratories Ltd881,62,735
Cipla Ltd251,19,333
Dr Reddys Laboratories Ltd191,04,603
Mankind Pharma Ltd491,03,575

Key Valuation Metric of Torrent Pharmaceuticals Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Torrent Pharmaceuticals Ltd

No data available

* All values are in %

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is one of the leading pharmaceutical companies having presence in Indian and global markets.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.
  • Apart from this, it has a modern and well-equipped state-of-the-art R&D Centre at Bhat near Ahmedabad, built with an investment of US $ 40 million.

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharmaceuticals announces change in senior management

Torrent Pharmaceuticals announced that Pranav Mehta has been elevated as Executive Directo...

Read more

2024-08-13 00:00:00

News

Torrent Pharma hits life as Gujarat unit gets EIR from USFDA

Earlier on 12 June 2024, the pharmaceutical company informed that the US FDA had conducted...

Read more

2024-08-30 00:00:00

News

Torrent Pharma's Madhya Pradesh facility concludes GMP inspection with 1 observation

The GMP inspection was conducted from 16 September to 20 September 2024. At the conclusion...

Read more

2024-09-20 00:00:00

News

Torrent Pharmaceuticals announces board meeting date

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25...

Read more

2024-10-10 00:00:00

News

Torrent Pharma Q2 PAT climbs 17% YoY to Rs 453 crore

Revenue from operations rose 8.60% year on year (YoY) to Rs 2,889 crore in the quarter end...

Read more

2024-10-26 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Torrent Pharmaceuticals Ltd

What is the current PE Ratio of Torrent Pharmaceuticals Ltd?

The Current PE Ratio of Torrent Pharmaceuticals Ltd is 65.4 as on 6 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 6 Dec 2024.

What was the PE Ratio of Torrent Pharmaceuticals Ltd last year?

The PE Ratio of Torrent Pharmaceuticals Ltd was 41.79 last year, now the PE ratio is 65.4, showing a year-on-year growth of 56.5%.

What does the PE Ratio of Torrent Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Torrent Pharmaceuticals Ltd is 65.4. This ratio indicates that investors are willing to pay 65.4 times the earnings per share for each share of Torrent Pharmaceuticals Ltd.

What is the PE Ratio Growth of Torrent Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Torrent Pharmaceuticals Ltd grew by 56.5% whereas, the EPS ratio grew by -1.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions